No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
1692 |
4. Check minimum number of eventsNone |
1692 |
5. Include endpointsNone |
1692 |
6. Filter based on genotype QC (FinnGen only) |
1641 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Clear cell adenocarcinoma of kidney
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of kidney, except renal pelvis
- Malignant neoplasm of urinary organs
- Malignant neoplasm of kidney, except renal pelvis, including Hilmo
- Solid cancers, helper endpoint
- Malignant neoplasm
Similar with less cases:
None
Case counts by codes
↥Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1641 | 626 | 1015 |
| Unadjusted period prevalence (%) | 0.37 | 0.22 | 0.47 |
| Median age at first event (years) | 68.14 | 68.61 | 67.86 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1692
- Matched controls
- 16920
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H02AB02
ATC
dexamethasone; systemic
28.1
313.8
217
88
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
307.7
1634
*
KAC10
NOMESCO Finland
Total nephrectomy with capsule
2693.1
307.7
388
*
JN4AD
NOMESCO Finland
Body CT examination
22.8
307.7
680
485
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
17.3
307.7
424
320
130
Kela drug reimbursment
Malignant tumour
+∞
307.7
475
*
C64
ICD-10 Finland
Malignant neoplasm of kidney, except renal pelvis
+∞
307.7
388
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
7.8
307.7
587
1082
B01AB10
ATC
tinzaparin; parenteral
14.8
307.7
634
657
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
307.7
1692
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
35.4
307.7
425
159
JN4BD
NOMESCO Finland
Extensive body CT
18.5
307.7
516
393
TPH07
NOMESCO Finland
Cathetrisation of artery
9.2
307.7
620
996
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
39.5
307.7
250
74
KAC11
NOMESCO Finland
Total nephrectomy with capsule, transcutaneous
1166.8
307.7
497
6
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
738.0
307.7
1309
78
JN4CD
NOMESCO Finland
Very extensive body CT
45.5
307.7
340
93
KAD01
NOMESCO Finland
Percutaneous endoscopic partial nephrectomy
413.1
280.0
274
8
197
Kela drug reimbursment
Sunitinib
+∞
274.7
256
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
264.7
247
*
KAD00
NOMESCO Finland
Partial nephrectomy
383.6
262.4
258
8
WX402
NOMESCO Finland
General anaesthesia
5.6
244.8
647
1685
A03FA01
ATC
metoclopramide; systemic, rectal
6.6
244.2
480
952
XX3DW
NOMESCO Finland
Time consuming IT work
9.7
242.7
313
388
WF002
NOMESCO Finland
Radical radiotherapy
87.6
231.4
122
15
Z51.5
ICD-10 Finland
Palliative care
10.6
225.9
267
294
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
12.8
221.1
226
201
WF049
NOMESCO Finland
Radiotherapy of metastasis
800.5
219.1
211
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
217.5
204
*
WX408
NOMESCO Finland
General anesthesy, balanced
4.8
217.4
750
2397
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
208.8
196
*
1502
Kela drug reimbursment
Cabozantinib
+∞
197.9
186
*
3012
Kela drug reimbursment
Cabozantinib
+∞
194.6
183
*
B01AB05
ATC
enoxaparin; parenteral
4.3
194.3
863
3279
WZC30
NOMESCO Finland
Teaching
5.2
183.9
475
1183
C61
ICD-10 Finland
Malignant neoplasm of prostate
1897.9
172.9
165
*
WZC00
NOMESCO Finland
Treatment plan or consultation
4.0
168.8
788
3037
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
13.1
162.5
161
135
L01XE04
ATC
[U] sunitinib
+∞
161.1
152
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
49.1
159.7
93
20
L01EX07
ATC
cabozantinib; oral
+∞
151.4
143
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
149.2
141
*
322
Kela drug reimbursment
Sunitinib
+∞
141.7
134
*
ZXE20
NOMESCO Finland
More than three and less than five hours
4.4
139.9
436
1238
KA1AE
NOMESCO Finland
Kidney ultrasound examination
11.2
137.1
150
146
159
Kela drug reimbursment
Pazopanib
+∞
131.0
124
*
N02AA05
ATC
oxycodone; systemic
4.0
129.0
457
1418
ZXC96
NOMESCO Finland
Robot assisted procedure
23.8
119.0
86
38
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
162.7
115.9
121
8
A04AA02
ATC
granisetron; systemic, transdermal
404.0
115.0
114
*
A04AA01
ATC
ondansetron; systemic, rectal
9.8
114.2
137
151
U75
ICPC
Malignant neoplasm of kidney
1174.5
114.0
110
*
JN3AD
NOMESCO Finland
Abdominal CT examination
4.3
112.5
347
966
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.2
111.4
1081
6082
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
109.6
104
*
L01EX01
ATC
sunitinib; oral
+∞
106.4
101
*
NK6AN
NOMESCO Finland
Total body bone isotope imaging
51.8
104.2
60
12
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
534.3
102.7
101
*
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
7.8
98.1
141
194
TPH04
NOMESCO Finland
Cathetrisation of vein
3.1
93.5
539
2225
N02AX02
ATC
tramadol; systemic, rectal
2.8
91.0
952
5365
L01XE26
ATC
[U] cabozantinib
+∞
85.1
81
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.2
83.2
424
1618
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
83.0
79
*
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
10.1
82.2
95
99
L01XE11
ATC
[U] pazopanib
+∞
79.8
76
*
116
Kela drug reimbursment
Prostate cancer
+∞
79.8
76
*
WX704
NOMESCO Finland
Intubation
4.2
78.8
229
602
R4110
NOMESCO Finland
Physiotherapy
2.7
78.3
614
2942
R31
ICD-10 Finland
Unspecified haematuria
3.5
75.8
311
1035
168
Kela drug reimbursment
Axitinib
+∞
75.6
72
*
158
Kela drug reimbursment
Everolimus
+∞
74.5
71
*
KAC00
NOMESCO Finland
Nephrectomy
261.4
74.0
75
*
ZXE10
NOMESCO Finland
More than one and less than three hours
2.5
73.8
734
3921
WF004
NOMESCO Finland
Palliative radiotherapy
749.9
73.8
72
*
115
Kela drug reimbursment
Breast cancer
+∞
66.1
63
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
7.6
64.8
94
130
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
119.8
64.3
69
6
KH1CD
NOMESCO Finland
Very extensive urinary tract ultrasound examination
13.2
62.5
60
47
UKC02
NOMESCO Finland
Cystoscopy
2.8
62.5
401
1709
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
10.0
61.3
71
74
N02BE01
ATC
paracetamol; systemic, rectal
5.5
60.3
1611
13252
GDB11
NOMESCO Finland
Thoracoscopic wedge resection of lung
22.6
59.8
44
20
PJA12
NOMESCO Finland
Sentinel node biopsy
313.3
59.7
60
*
WW500
NOMESCO Finland
Blood transfusion
7.6
59.7
86
118
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
57.6
55
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
57.6
55
*
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
22.6
57.2
42
19
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.7
56.8
388
1699
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
56.6
54
*
ZXE30
NOMESCO Finland
More than five and less than seven hours
4.8
55.9
132
293
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
5.6
55.5
108
202
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.4
55.0
218
703
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
+∞
54.5
52
*
343
Kela drug reimbursment
Pazopanib
+∞
54.5
52
*
361
Kela drug reimbursment
Axitinib
+∞
54.5
52
*
ZX120
NOMESCO Finland
Intravenous
3.7
54.3
190
565
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.5
53.7
203
635
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.8
53.6
180
520
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.2
53.4
236
813
A06AH03
ATC
naloxegol; oral
17.6
52.4
43
25
S18
ICPC
Laceration/cut
2.2
52.4
905
5860
GD1AD
NOMESCO Finland
Thorax CT examination
4.0
52.3
161
438
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
4.9
52.2
119
256
KA3LT
NOMESCO Finland
Njurlesion coagulation
185.8
52.2
54
*
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
4.4
51.8
138
337
U14
ICPC
Kidney symptom/complaint
7.4
51.5
76
107
WX110
NOMESCO Finland
Infiltration anesthesia
2.3
50.1
1231
9088
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
49.2
47
*
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
4.0
47.8
146
394
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
480.9
47.6
47
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.8
47.4
156
444
L02AE02
ATC
leuprorelin; implant, parenteral
89.4
47.1
52
6
WX725
NOMESCO Finland
Noninvasive ventilation
3.9
46.5
146
402
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
46.0
44
*
KAC01
NOMESCO Finland
Percutaneous endoscopic nephrectomy
+∞
46.0
44
*
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
3.9
46.0
142
386
A79
ICPC
Malignancy NOS
126.1
46.0
49
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
4.0
45.4
136
362
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
45.0
43
*
L01EK01
ATC
axitinib; oral
+∞
45.0
43
*
C64.80
ICD-10 Finland
Wilms tumour
+∞
43.9
42
*
Y77
ICPC
Malignant neoplasm prostate
438.5
43.4
43
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
438.5
43.4
43
*
JN1CD
NOMESCO Finland
Very extensive CT examination of upper part of abdomen
12.2
42.9
43
36
340
Kela drug reimbursment
Everolimus
+∞
42.9
41
*
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
7.6
42.2
60
81
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
41.8
40
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
41.8
40
*
C08CA01
ATC
amlodipine; oral
2.0
41.6
851
5697
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.8
40.9
227
883
KCD02
NOMESCO Finland
Transurethral resection of bladder
16.5
40.1
34
21
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
210.0
40.0
41
*
D44.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Adrenal gland
9.3
38.7
47
52
L01XE10
ATC
[U] everolimus
+∞
38.7
37
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
38.7
37
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
38.7
37
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.7
38.5
239
984
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
12.5
38.5
38
31
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
6.7
38.5
62
96
ZX090
NOMESCO Finland
Other technic of radiotherapy
86.2
38.0
42
5
D41.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Renal pelvis
86.2
38.0
42
5
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
86.2
38.0
42
5
JN6AD
NOMESCO Finland
CT of torso and neck
12.1
37.7
38
32
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
37.6
36
*
M05BX04
ATC
denosumab; parenteral
3.6
37.1
129
380
WF003
NOMESCO Finland
Adjuvant radiotherapy
194.2
36.9
38
*
D30.0
ICD-10 Finland
Benign neoplasm: Kidney
10.0
35.7
41
42
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
354.3
35.1
35
*
L02BG04
ATC
letrozole; oral
47.8
34.8
42
9
N18.8
ICD-10 Finland
Other chronic renal failure
4.6
34.2
84
192
AA1BD
NOMESCO Finland
Extensive CT of head and brain
6.0
34.1
61
105
HAC20
NOMESCO Finland
Total mastectomy
178.6
33.8
35
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
122.6
33.8
36
*
L01XE17
ATC
[U] axitinib
+∞
33.4
32
*
ZXD10
NOMESCO Finland
Scheduled procedure
1.9
32.9
657
4266
KH1AD
NOMESCO Finland
CT of urinary organs
4.0
32.8
97
255
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
55.5
32.4
38
7
L01EX03
ATC
pazopanib; oral
+∞
31.3
30
*
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
31.3
30
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
31.3
30
*
L01BC06
ATC
capecitabine; oral
+∞
31.3
30
*
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
9.9
31.3
36
37
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
71.3
31.0
35
5
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
2.2
30.6
300
1507
R93.4
ICD-10 Finland
Abnormal findings on diagnostic imaging of urinary organs
8.7
30.6
39
46
SPAT1153
SPAT
Removal of sutures
1.9
30.6
597
3828
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
31.5
30.4
40
13
ZXA05
NOMESCO Finland
Left side
1.9
30.0
470
2801
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
3.1
29.7
127
425
198
Kela drug reimbursment
Sorafenib
+∞
29.2
28
*
L01EG02
ATC
everolimus; oral
+∞
29.2
28
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.0
29.2
363
1994
R50.9
ICD-10 Finland
Fever, unspecified
2.3
29.0
261
1264
V03AE01
ATC
polystyrene sulfonate; oral
6.9
29.0
45
67
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
7.2
28.9
43
61
C03CA01
ATC
furosemide; systemic
1.8
28.3
595
3882
XKD00
NOMESCO Finland
Uroflowmetry
2.1
28.2
333
1792
C50.99
ICD-10 Finland
Breast, unspecified
+∞
28.2
27
*
R4190
NOMESCO Finland
Nutritional therapy
4.7
28.2
66
145
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
27.2
26
*
C79.7
ICD-10 Finland
Secondary malignant neoplasm of adrenal gland
+∞
27.2
26
*
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
3.3
27.1
106
336
TK800
NOMESCO Finland
Hemodialysis
4.7
27.0
63
138
B03XA02
ATC
darbepoetin alfa; parenteral
5.4
26.9
53
100
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
275.3
26.8
27
*
L03AA13
ATC
pegfilgrastim; parenteral
98.3
26.7
29
*
L03AA02
ATC
filgrastim; parenteral
46.5
26.5
32
7
L02BB03
ATC
bicalutamide; oral
+∞
26.1
25
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
26.1
25
*
I10
ICD-10 Finland
Essential (primary) hypertension
1.8
25.9
1191
9631
BCA30
NOMESCO Finland
Unilateral adrenalectomy
264.5
25.8
26
*
A02BC02
ATC
pantoprazole; systemic
1.8
25.7
1153
9245
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
3.3
25.3
99
314
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
25.1
24
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
25.1
24
*
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
253.8
24.7
25
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
5.0
24.7
53
108
ZX050
NOMESCO Finland
Stereotactic radiotherapy
49.1
24.3
29
6
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
+∞
24.0
23
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
68.5
23.9
27
*
B01AB04
ATC
dalteparin; parenteral
3.2
23.5
98
323
ZXE00
NOMESCO Finland
One hour or less
1.7
23.3
605
4143
J01DB01
ATC
cefalexin; oral
1.9
23.1
1360
11600
ZZR00
NOMESCO Finland
Flap of skin
9.2
23.0
28
31
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
23.0
22
*
PJD43
NOMESCO Finland
Excision of aortic lymph nodes
+∞
23.0
22
*
PHE70
NOMESCO Finland
Thrombectomy of inferior vena cava
+∞
23.0
22
*
N02AA01
ATC
morphine; systemic, rectal
6.2
22.9
39
64
M04AA01
ATC
allopurinol; systemic
2.0
22.6
280
1524
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.5
22.4
145
605
A11CC03
ATC
alfacalcidol; systemic
4.1
22.2
61
152
ZXA00
NOMESCO Finland
Right side
1.7
22.1
485
3161
WX892
NOMESCO Finland
Monitored bed care
2.4
22.1
160
703
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
21.9
21
*
C65
ICD-10 Finland
Malignant neoplasm of renal pelvis
+∞
21.9
21
*
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
21.9
21
*
PHN71
NOMESCO Finland
Excision of tumor mass from inferior vena cava
+∞
20.9
20
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
20.9
20
*
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.7
20.4
114
442
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.2
20.3
192
943
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.7
20.1
501
3365
WX290
NOMESCO Finland
Other blockage of nerve
1.6
20.1
669
4841
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
4.0
20.1
58
150
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
58.2
19.9
23
*
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
+∞
19.8
19
*
KA4AT
NOMESCO Finland
Cytology of kidney with ultrasound guidance
74.4
19.7
22
*
BCA31
NOMESCO Finland
Endoscopic unilateral adrenalectomy
15.8
19.3
31
20
M84.4
ICD-10 Finland
Pathological fracture, not elsewhere classified
31.7
19.3
25
8
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
3.9
19.0
56
147
Z31.5
ICD-10 Finland
Genetic counselling
3.6
18.8
62
176
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
+∞
18.8
18
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
18.8
18
*
Z85.5
ICD-10 Finland
Personal history of malignant neoplasm of urinary tract
+∞
18.8
18
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
18.8
18
*
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.0
18.6
208
1087
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
2.9
18.5
91
330
J01MA02
ATC
ciprofloxacin; systemic
1.6
18.4
654
4781
HA1AA
NOMESCO Finland
X-ray mammography
3.8
18.3
56
151
Z3226
NOMESCO Finland
Physiotherapist
1.8
18.1
302
1803
XX2RW, ,
NOMESCO Finland
14.5
18.1
30
21
ZXD05
NOMESCO Finland
Urgent procedure
1.7
18.0
482
3282
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.1
17.9
177
883
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
3.0
17.8
82
287
L01XE05
ATC
[U] sorafenib
+∞
17.7
17
*
H02AB06
ATC
prednisolone; systemic
1.6
17.7
774
5921
E0000UV, ,
ATC
1.6
17.7
630
4597
N28.1
ICD-10 Finland
Cyst of kidney
4.3
17.7
45
106
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
4.1
17.6
48
119
U06
ICPC
Haematuria
3.4
17.6
64
194
WX306
NOMESCO Finland
Lumbar epidural anesthesy
3.1
17.5
73
241
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
29.1
17.4
23
8
HAB40
NOMESCO Finland
Wedge excision of mammary gland
15.0
17.1
28
19
AA1AD
NOMESCO Finland
CT of head and brain
1.6
17.1
519
3639
J01MA12
ATC
levofloxacin; systemic
1.8
17.0
307
1876
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
3.7
16.9
54
150
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
16.7
16
*
M49.5*C79.5
ICD-10 Finland
Metastatic fracture of vertebra
+∞
16.7
16
*
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
+∞
16.7
16
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
16.7
16
*
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
+∞
16.7
16
*
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
27.8
16.5
22
8
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.7
16.3
339
2154
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
3.2
16.2
63
199
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
48.0
16.0
19
*
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
6.4
15.8
26
41
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
60.6
15.8
18
*
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
6.7
15.8
25
38
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
4.9
15.7
34
70
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.2
15.7
135
637
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
13.0
15.7
27
21
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
+∞
15.6
15
*
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
+∞
15.6
15
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
15.6
15
*
TQW99
NOMESCO Finland
Other minor procedure on skin
2.8
15.5
79
292
H02AB09
ATC
hydrocortisone; systemic
3.8
15.4
46
122
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
38.4
15.4
19
5
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
14.9
15.4
25
17
JAD11
NOMESCO Finland
Laparoscopic repair of incisional hernia
5.2
15.3
31
60
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
7.1
15.3
23
33
Z3231
NOMESCO Finland
Registered nurse
1.6
15.2
419
2857
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.7
15.0
79
297
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.6
14.9
90
363
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
5.2
14.9
30
58
D64.9
ICD-10 Finland
Anaemia, unspecified
1.9
14.8
197
1091
L02BA01
ATC
tamoxifen; oral
57.2
14.8
17
*
PC5DT
NOMESCO Finland
Embolisation of tumor of kidney
+∞
14.6
14
*
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
+∞
14.6
14
*
A04AD12
ATC
aprepitant; systemic
+∞
14.6
14
*
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
+∞
14.6
14
*
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
5.2
14.6
30
59
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
151.3
14.5
15
*
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
151.3
14.5
15
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
151.3
14.5
15
*
A10BH05
ATC
linagliptin; oral
2.2
14.5
120
558
205
Kela drug reimbursment
Chronic hypertension
1.5
14.4
529
3848
ZXE40
NOMESCO Finland
More than seven and less than nine hours
3.6
14.3
46
129
G04CA02
ATC
tamsulosin; oral
1.6
14.2
501
3608
E87.5
ICD-10 Finland
Hyperkalaemia
3.6
14.0
46
131
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.2
14.0
121
573
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
30.3
13.9
18
6
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
6.3
13.8
23
37
Z03.1
ICD-10 Finland
Observation for suspected malignant neoplasm
5.0
13.6
29
59
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
13.6
13
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
13.6
13
*
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
+∞
13.6
13
*
JAH01
NOMESCO Finland
Laparoscopy
3.2
13.5
54
174
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
141.1
13.5
14
*
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
2.7
13.4
72
274
Z90.5
ICD-10 Finland
Acquired absence of kidney
40.4
13.2
16
*
H03AA01
ATC
levothyroxine sodium; systemic
1.6
13.0
334
2229
TGD00
NOMESCO Finland
Needle biopsy of lung
28.6
13.0
17
6
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
22.7
12.9
18
8
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
3.9
12.8
37
96
WVA40
NOMESCO Finland
Initiation and monitoring of intravenous hydration
4.2
12.7
33
79
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
5.2
12.7
26
51
N05CF01
ATC
zopiclone; oral
1.5
12.7
498
3655
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
12.4
12.6
22
18
WX600
NOMESCO Finland
Single shot through catheter
11.1
12.5
23
21
OAB38
NOMESCO Finland
Psychosocial guidance and counselling
+∞
12.5
12
*
C44.81
ICD-10 Finland
Overall basocellular carcinoma of the skin
+∞
12.5
12
*
C78.1
ICD-10 Finland
Secondary malignant neoplasm of mediastinum
+∞
12.5
12
*
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
+∞
12.5
12
*
C50
ICD-10 Finland
Malignant neoplasm of breast
130.9
12.4
13
*
XX1XW
NOMESCO Finland
Extensive written report from radiologist
3.6
12.4
41
117
TKC20
NOMESCO Finland
Catheterisation of bladder
2.1
12.4
123
614
E83.50
ICD-10 Finland
Hypercalcemia
4.9
12.4
27
56
WX002
NOMESCO Finland
Sedation and analgesia
1.6
12.4
321
2145
KCW02
NOMESCO Finland
Lavation of bladder for coagulated blood
5.4
12.3
24
45
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.0
12.1
52
175
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.5
12.0
503
3732
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.1
12.0
122
615
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
3.5
12.0
41
120
A06AD11
ATC
lactulose; oral
1.7
11.8
241
1512
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
5.6
11.7
22
40
XW000
NOMESCO Finland
Bone marrow biopsy
2.7
11.6
60
224
KBJ10
NOMESCO Finland
Cutaneous ureteroenterostomy
+∞
11.5
11
*
L02AE04
ATC
triptorelin; parenteral
+∞
11.5
11
*
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
11.5
11
*
M907, C6488,
ICD-10 Finland
+∞
11.5
11
*
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
11.5
11
*
C34.32
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
+∞
11.5
11
*
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
+∞
11.5
11
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
11.5
11
*
8130/2-C67.9
ICD-O-3
Papillary urothelial carcinoma, non-invasive of bladder, NOS
+∞
11.5
11
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
11.5
11
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
11.5
11
*
E89.6
ICD-10 Finland
Postprocedural adrenocortical(-medullary) hypofunction
120.8
11.4
12
*
Z51.0
ICD-10 Finland
Radiotherapy session
120.8
11.4
12
*
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
120.8
11.4
12
*
JAD30
NOMESCO Finland
Repair of incisional hernia using prosthetic material
3.5
11.3
38
110
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
1.8
11.3
172
994
WPA10
NOMESCO Finland
Proactive palliative care treatment plan
17.2
11.2
17
10
RJ128, ,
NOMESCO Finland
12.8
11.1
19
15
ZXK00
NOMESCO Finland
Conversion from percutaneous endoscopic to open procedure
11.2
11.0
20
18
JFB30
NOMESCO Finland
Right hemicolectomy
10.1
11.0
21
21
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
4.7
11.0
25
54
KB1CG
NOMESCO Finland
Extensive MRI examination of urinary tract with high intensity magnet
43.6
10.9
13
*
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
10.8
658
5222
J94.8
ICD-10 Finland
Other specified pleural conditions
3.8
10.8
32
85
X76
ICPC
Malignant neoplasm breast female
60.4
10.6
12
*
D75
ICPC
Malignant neoplasm colon/rectum
60.4
10.6
12
*
R23.8
ICD-10 Finland
Other and unspecified skin changes
1.6
10.6
259
1701
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.0
10.6
114
587
N99.0
ICD-10 Finland
Postprocedural renal failure
110.7
10.4
11
*
C90.0
ICD-10 Finland
Multiple myeloma
110.7
10.4
11
*
D41
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of urinary organs
110.7
10.4
11
*
C83.00
ICD-10 Finland
Lymphocytic lymphoma
+∞
10.4
10
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
10.4
10
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
10.4
10
*
C82.1
ICD-10 Finland
Follicular lymphoma grade II
+∞
10.4
10
*
C79.0
ICD-10 Finland
Secondary malignant neoplasm of kidney and renal pelvis
+∞
10.4
10
*
C50.31
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor
+∞
10.4
10
*
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
+∞
10.4
10
*
180
Kela drug reimbursment
Interferon alfa
+∞
10.4
10
*
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
+∞
10.4
10
*
L02BX02
ATC
degarelix; parenteral
+∞
10.4
10
*
C44.11
ICD-10 Finland
Basocellular carcinoma of the skin of the eyelids including the corner of the eye
+∞
10.4
10
*
323
Kela drug reimbursment
Sorafenib
+∞
10.4
10
*
L02BG03
ATC
anastrozole; oral
+∞
10.4
10
*
XF600
NOMESCO Finland
Bloodpressure measurement
2.1
10.4
105
528
SPAT1254
SPAT
Administration of medicine
1.6
10.4
231
1481
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
32.7
10.3
13
*
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
18.9
10.3
15
8
L57.0
ICD-10 Finland
Actinic keratosis
1.9
10.2
142
798
TPX10
NOMESCO Finland
Implantation of vascular injection port
3.2
10.2
39
123
WVA20
NOMESCO Finland
Medicine administration
3.0
10.2
43
144
Z2221
NOMESCO Finland
Medical doctor
1.5
10.1
371
2667
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
4.2
10.1
26
62
N18.0
ICD-10 Finland
End-stage renal disease
4.2
10.1
26
62
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
10.1
613
4847
N03AX16
ATC
[U] pregabalin
1.5
10.1
356
2539
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
11.4
10.1
18
16
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.7
9.9
210
1329
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
20.2
9.8
14
7
A12AA04
ATC
calcium carbonate; oral
3.6
9.8
32
91
N18.4
ICD-10 Finland
Chronic kidney disease, stage 4
4.0
9.8
27
68
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
4.6
9.8
23
51
A28
ICPC
Limited function/disability NOS
1.6
9.8
291
1999
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
2.2
9.8
80
371
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
2.5
9.8
59
239
OAB42
NOMESCO Finland
Guidance related to known health problem
13.4
9.7
16
12
JMA10
NOMESCO Finland
Transabdominal total splenectomy
13.4
9.7
16
12
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
55.3
9.7
11
*
NK6BQ
NOMESCO Finland
Whole body extensive bone SPET with low dose CT
55.3
9.7
11
*
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
55.3
9.7
11
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.4
9.6
461
3491
ZX112
NOMESCO Finland
Subcutaneous
4.8
9.5
21
44
A29
ICPC
General symptom/complaint other
1.7
9.5
205
1303
PG1PT
NOMESCO Finland
Extensive endovascular embolisation for bleeding with radiological guidance not elsewhere classified
10.1
9.5
18
18
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
15.1
9.5
15
10
A09AA02
ATC
multienzymes (lipase, protease etc.); oral
3.2
9.5
36
113
WX882
NOMESCO Finland
High dependency care
2.8
9.4
46
167
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
30.2
9.4
12
*
GDB10
NOMESCO Finland
Wedge resection of lung
30.2
9.4
12
*
WF099
NOMESCO Finland
Other radiotherapy
17.6
9.4
14
8
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.3
9.4
70
312
C18.01
ICD-10 Finland
Malignant tumor of the caecum invasive carcinoma
+∞
9.4
9
*
8140/3-C18.0
ICD-O-3
Adenocarcinoma, NOS, of cecum
+∞
9.4
9
*
C50.4
ICD-10 Finland
Malignant neoplasm: Upper-outer quadrant of breast
+∞
9.4
9
*
YX9AW, ,
NOMESCO Finland
+∞
9.4
9
*
YN1AD
NOMESCO Finland
CT examination of extremities for dose design of radiotherapy
+∞
9.4
9
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
9.4
9
*
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
+∞
9.4
9
*
1XC17, ,
NOMESCO Finland
+∞
9.4
9
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
9.4
9
*
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
+∞
9.4
9
*
PJD53
NOMESCO Finland
Block dissection of aortic lymph nodes
+∞
9.4
9
*
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
+∞
9.4
9
*
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
+∞
9.4
9
*
8500/3-C50.2
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast
+∞
9.4
9
*
TJF80
NOMESCO Finland
Ostomy education
12.4
9.4
16
13
WPA15
NOMESCO Finland
Palliative care consultation with the patient and loved ones
13.7
9.2
15
11
C09BA02
ATC
enalapril and diuretics; systemic
1.7
9.1
153
910
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
3.2
9.1
35
111
GD1AT
NOMESCO Finland
Biopsy of the lung with ultrasound guidance
36.9
9.0
11
*
SPAT1262
SPAT
Handing over of treatment supplies
1.5
9.0
304
2146
WPB10
NOMESCO Finland
Making a convalescent care decision
18.7
8.9
13
7
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
2.5
8.9
53
213
JLC10
NOMESCO Finland
Distal pancreatectomy
24.1
8.9
12
5
C02AC05
ATC
moxonidine; oral
2.0
8.9
96
496
N18.5
ICD-10 Finland
Chronic kidney disease, stage 5
4.5
8.8
21
47
KDE20
NOMESCO Finland
Removal of foreign body from urethra
10.8
8.8
16
15
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
3.5
8.8
30
88
GDC00
NOMESCO Finland
Lobectomy of lung
50.2
8.7
10
*
KH1BD
NOMESCO Finland
Extensive urinary tract CT examination
6.6
8.7
21
32
UJF32
NOMESCO Finland
Coloscopy
1.4
8.5
396
2969
C08CA02
ATC
felodipine; oral
1.7
8.5
177
1114
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
3.8
8.5
25
66
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
20.1
8.5
12
6
T90
ICPC
Diabetes non-insulin dependent
1.4
8.4
443
3395
128
Kela drug reimbursment
Cancers of female genital organs
90.5
8.4
9
*
R84
ICPC
Malignant neoplasm bronchus/lung
90.5
8.4
9
*
KKB10
NOMESCO Finland
Excision of retroperitoneal tumour
90.5
8.4
9
*
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
12.8
8.4
14
11
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
3.4
8.4
29
86
XX9XW, ,
NOMESCO Finland
7.9
8.4
18
23
UKC05
NOMESCO Finland
Cystoscopy and bladder biopsy
6.7
8.4
20
30
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
8.3
8
*
8097/3-C44.9
ICD-O-3
Basal cell carcinoma, nodular of skin, NOS
+∞
8.3
8
*
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
+∞
8.3
8
*
390
Kela drug reimbursment
Ibrutinib
+∞
8.3
8
*
8090/3-C44.4
ICD-O-3
Basal cell carcinoma, NOS, of skin of scalp and neck
+∞
8.3
8
*
C15.5
ICD-10 Finland
Malignant neoplasm: Lower third of oesophagus
+∞
8.3
8
*
C18.20
ICD-10 Finland
Malignant tumor of the ascending colon without histology
+∞
8.3
8
*
8380/3-C54.1
ICD-O-3
Endometrioid adenocarcinoma, NOS, of endometrium
+∞
8.3
8
*
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
+∞
8.3
8
*
WF001
NOMESCO Finland
Preoperative radiotherapy
+∞
8.3
8
*
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
+∞
8.3
8
*
C02.11
ICD-10 Finland
Malignant neoplasm of border of tongue
+∞
8.3
8
*
C20.92
ICD-10 Finland
Malignant tumor of the rectum carcinoma of the adenoma
+∞
8.3
8
*
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
+∞
8.3
8
*
M90.7*C90.0
ICD-10 Finland
Pathological fracture in multiple myeloma
+∞
8.3
8
*
WF090
NOMESCO Finland
Profylactic radiotherapy
+∞
8.3
8
*
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
+∞
8.3
8
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
8.3
8
*
D11.0
ICD-10 Finland
Benign neoplasm: Parotid gland
3.1
8.3
34
112
KWD00
NOMESCO Finland
Reoperation for superficial haemorrhage in urological surgery
14.5
8.2
13
9
M10.9
ICD-10 Finland
Gout, unspecified
1.7
8.2
140
836
C10AA07
ATC
rosuvastatin; oral
0.7
8.2
350
4611
NF3AA
NOMESCO Finland
Femur X-ray examination
2.9
8.1
38
135
ZX100
NOMESCO Finland
Oral
3.6
8.1
26
73
WX250
NOMESCO Finland
Intercostal blockade
33.5
8.1
10
*
C44.71
ICD-10 Finland
Basocellular carcinoma of the skin of the lower extremity including the hip
33.5
8.1
10
*
JG1CG
NOMESCO Finland
Extensive MRI of rectum
33.5
8.1
10
*
105
Kela drug reimbursment
Adrenal cortical hypofunction
17.3
8.1
12
7
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.1
8.1
70
333
KC1GB
NOMESCO Finland
Cystography with X-ray
22.1
8.0
11
5
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.6
8.0
210
1399
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.4
8.0
387
2921
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
7.3
8.0
18
25
-44
ICPC
Preventive immunization/medic
1.7
7.9
132
783
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.3
7.9
730
6111
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
4.7
7.9
18
39
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
3.6
7.9
25
70
K43.2
ICD-10 Finland
Incisional hernia without obstruction or gangrene
8.5
7.8
16
19
S54
ICPC
Skin, Repair/fix-suture/cast/prosth device
2.4
7.8
51
215
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
2.6
7.8
43
167
D41.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Urinary organ, unspecified
45.2
7.7
9
*
I50.9
ICD-10 Finland
Heart failure, unspecified
1.5
7.7
242
1678
TKE00
NOMESCO Finland
Needle biopsy of prostate
2.5
7.6
45
181
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.3
7.6
58
262
XJH00
NOMESCO Finland
Transanal ultrasonography
1.9
7.6
97
531
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
2.8
7.5
37
136
JEA01
NOMESCO Finland
Laparoscopic appendectomy
2.6
7.5
42
165
R86.0
ICD-10 Finland
Abnormal findings in specimens from male genital organs, abnormal level of enzymes
3.1
7.4
30
98
N03AX14
ATC
levetiracetam; systemic
2.5
7.4
44
177
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
80.4
7.4
8
*
U79
ICPC
Neoplasm urinary tract unspecified
80.4
7.4
8
*
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
80.4
7.4
8
*
YJ1AD
NOMESCO Finland
CT examination of abdomen for dose design of radiotherapy
80.4
7.4
8
*
G04BE03
ATC
sildenafil; oral
6.5
7.4
18
28
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
2.8
7.3
35
126
PHC70
NOMESCO Finland
Suture of inferior vena cava
+∞
7.3
7
*
L01EX02
ATC
sorafenib; oral
+∞
7.3
7
*
8140/3-C34.3
ICD-O-3
Adenocarcinoma, NOS, of lower lobe, lung
+∞
7.3
7
*
JJB10
NOMESCO Finland
Atypcal resection of liver
+∞
7.3
7
*
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
+∞
7.3
7
*
PHN70
NOMESCO Finland
Plastic repair of inferior vena cava
+∞
7.3
7
*
C79.31
ICD-10 Finland
Secondary malignant tumor of the cerebellum
+∞
7.3
7
*
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
+∞
7.3
7
*
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
7.3
7
*
C18.21
ICD-10 Finland
Malignant tumor of the ascending colon invasive carcinoma
+∞
7.3
7
*
C71.90
ICD-10 Finland
Malignant tumor in unspecified localization in the brain without histology
+∞
7.3
7
*
D64.8
ICD-10 Finland
Other specified anaemias
2.9
7.3
32
110
C08CA13
ATC
lercanidipine; oral
1.5
7.3
258
1833
P01AB01
ATC
metronidazole; oral, rectal
1.3
7.3
548
4437
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
30.1
7.1
9
*
C09CA01
ATC
losartan; oral
1.4
7.1
443
3479
K46.9
ICD-10 Finland
Unspecified abdominal hernia without obstruction or gangrene
6.6
7.1
17
26
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
8.0
7.1
15
19
-54
ICPC
Repair/fix-suture/cast/prosth device
2.8
7.1
34
123
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
3.5
7.0
23
66
379
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism
2.4
7.0
46
195
Z49.1
ICD-10 Finland
Extracorporeal dialysis
3.2
7.0
26
81
Z49.0
ICD-10 Finland
Preparatory care for dialysis
3.4
7.0
24
71
N18
ICD-10 Finland
Chronic kidney disease
3.3
7.0
25
76
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
4.4
7.0
17
39
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
3.0
6.9
29
97
C07AB07
ATC
bisoprolol; oral
1.3
6.9
850
7361
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
3.2
6.9
26
82
B01AF02
ATC
apixaban; oral
1.5
6.8
229
1608
A10AE04
ATC
insulin glargine; parenteral
1.6
6.8
165
1079
GEA20
NOMESCO Finland
Mediastinoscopy with excision of lesion
16.8
6.7
10
6
R33
ICD-10 Finland
Retention of urine
1.7
6.7
133
829
N05BA04
ATC
oxazepam; oral
1.4
6.7
355
2715
GD5CD
NOMESCO Finland
Thorax and upper abdomen combined very extensive CT examination of
6.5
6.6
16
25
E03.2
ICD-10 Finland
Hypothyroidism due to medicaments and other exogenous substances
7.8
6.6
14
18
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
3.5
6.6
22
64
BA1AE
NOMESCO Finland
Thyroiid ultrasound examination
3.3
6.6
24
74
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
8.7
6.6
13
15
WW200, ,
SPAT
0.7
6.5
214
2980
J01CA04
ATC
amoxicillin; systemic
1.3
6.5
1214
11091
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
1.7
6.5
124
765
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.5
6.5
39
159
R11
ICD-10 Finland
Nausea and vomiting
1.7
6.5
106
627
E89.01
ICD-10 Finland
Postsurgical hypothyroidism
3.5
6.4
21
60
H02AA02
ATC
fludrocortisone; oral
3.9
6.4
18
46
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
70.1
6.4
7
*
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
6.6
6.3
15
23
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.3
6.3
676
5723
JAH00
NOMESCO Finland
Laparotomy
2.6
6.3
35
137
XF612
NOMESCO Finland
Measurement of central venous pressure
18.1
6.3
9
5
8720/3-C44.5
ICD-O-3
Malignant melanoma, NOS, of skin of trunk
+∞
6.3
6
*
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
+∞
6.3
6
*
NAR00
NOMESCO Finland
Complete excision of tumour of bone or cartilage of spine, unspecified
+∞
6.3
6
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
6.3
6
*
D63.0
ICD-10 Finland
Anaemia in neoplastic disease
+∞
6.3
6
*
KA3CT
NOMESCO Finland
Biopsy of kidney under CT guidance
+∞
6.3
6
*
1512
Kela drug reimbursment
Ibrutinib
+∞
6.3
6
*
8140/3-C34.1
ICD-O-3
Adenocarcinoma, NOS, of upper lobe, lung
+∞
6.3
6
*
8140/3-C18.4
ICD-O-3
Adenocarcinoma, NOS, of transverse colon
+∞
6.3
6
*
8170/3-C22.0
ICD-O-3
Hepatocellular carcinoma, NOS, of liver
+∞
6.3
6
*
C18.40
ICD-10 Finland
Malignant tumor of the transverse colon without histology
+∞
6.3
6
*
L01CA04
ATC
vinorelbine; systemic
+∞
6.3
6
*
PJD99
NOMESCO Finland
Excision of other lymph nodes
+∞
6.3
6
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
6.3
6
*
ZX022
NOMESCO Finland
LDR radiotherapy within tissue
+∞
6.3
6
*
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
+∞
6.3
6
*
8070/3-C02.1
ICD-O-3
Squamous cell carcinoma, NOS, of border of tongue
+∞
6.3
6
*
YN1BD
NOMESCO Finland
Extensive CT examination of extremities for dose design of radiotherapy
+∞
6.3
6
*
C16.9
ICD-10 Finland
Malignant neoplasm: Stomach, unspecified
+∞
6.3
6
*
C69.30
ICD-10 Finland
Malignant tumor of the chorioidea without histology
+∞
6.3
6
*
C79.39
ICD-10 Finland
Secondary malignant tumor of the meninges, ventricle or other part of the brain
+∞
6.3
6
*
PC6FT
NOMESCO Finland
Endovascular very extensive embolisation of spinal lesion
+∞
6.3
6
*
WB303
NOMESCO Finland
Simple adjuvant therapy of malignancy with biomodifiers
+∞
6.3
6
*
9732/3-C42.1
ICD-O-3
Plasma cell myeloma of bone marrow
+∞
6.3
6
*
GDB21
NOMESCO Finland
Thoracoscopic segmental resection of lung
+∞
6.3
6
*
C73
ICD-10 Finland
Malignant neoplasm of thyroid gland
+∞
6.3
6
*
C56.71
ICD-10 Finland
Serous epithelial malignant tumor of the ovary
+∞
6.3
6
*
8090/3-C44.2
ICD-O-3
Basal cell carcinoma, NOS, of external ear
+∞
6.3
6
*
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
+∞
6.3
6
*
JKA20
NOMESCO Finland
Cholecystectomy
2.4
6.2
41
174
GDA21
NOMESCO Finland
Thoracoscopic excision of lesion of lung
26.8
6.2
8
*
XX1AD
NOMESCO Finland
Other CT-examination
26.8
6.2
8
*
JLC30
NOMESCO Finland
Pancreatoduodenectomy
26.8
6.2
8
*
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.3
6.2
427
3395
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.3
6.2
433
3453
Z2446
NOMESCO Finland
Social worker
1.9
6.2
79
434
J01EA01
ATC
trimethoprim; systemic
1.4
6.1
307
2321
C09AA02
ATC
enalapril; systemic
1.4
6.1
331
2534
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
0.2
6.1
6
296
D70.82
ICD-10 Finland
Drug-induced neutropenia
8.6
6.1
12
14
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
8.6
6.1
12
14
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
3.6
6.0
19
53
PC1CC
NOMESCO Finland
Very extensive angiography of aorta and abdominal arteries
10.1
6.0
11
11
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
10.1
6.0
11
11
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
1293
5832
6.16
250.03
3.2
2.3
—
—
—
0
0
394
774
6.33
199.72
7.3
10.4
—
—
—
0
0
524
1370
5.09
192.19
4.4
2.7
223.29
235.51
u/l
1.80
514
1277
1191
5750
4.62
190.54
8.1
3.9
34.52
35.57
g/l
7.95
1136
5287
1275
6599
4.78
182.09
12.4
3.8
10.81
12.35
umol/l
4.86
1238
6185
511
1398
4.80
175.68
7.3
8.1
120.47
123.18
g/l
2.24
501
1365
533
1526
4.64
172.64
7.0
7.7
96.86
95.18
%
10.51
518
1470
1215
6271
4.33
168.94
9.4
5.4
1.20
1.21
mmol/l
1.81
1157
5587
937
4074
3.91
167.52
4.7
3.0
73.50
76.08
e6/l
0.04
782
3109
555
1681
4.43
166.29
7.0
7.3
-0.14
1.23
mmol/l
14.04
456
1331
554
1684
4.40
165.06
7.0
7.3
5.34
5.09
kpa
7.96
538
1612
553
1684
4.39
164.27
7.0
7.3
14.01
11.55
kpa
18.25
537
1612
871
3735
3.75
156.24
4.5
3.0
0.40
0.44
e6/l
0.10
726
2829
1456
8848
5.63
155.26
5.8
4.3
853.40
2650.12
e6/l
0.79
15
129
333
721
5.51
149.54
8.2
9.7
23.55
24.34
mmol/l
4.55
328
702
1245
6907
4.04
146.85
10.9
5.8
1.20
1.21
mmol/l
3.22
1044
5886
1578
10486
8.49
144.60
15.3
5.4
82.09
76.09
u/l
7.27
1552
9712
1382
8419
4.50
137.74
7.3
4.5
6.93
6.89
mmol/l
0.31
1346
7893
724
2947
3.55
136.95
2.7
2.1
—
—
—
0
0
973
4756
3.46
136.67
5.3
3.5
64.58
105.75
e6/l
1.08
799
3357
440
1300
4.22
133.32
7.4
6.9
11.05
10.71
mmol/l
0.41
421
1231
1205
6947
3.55
124.63
15.3
17.9
1.21
1.36
inr
6.98
368
1962
1235
7295
3.57
121.30
14.6
6.2
4.28
4.34
e9/l
0.38
1088
6285
298
696
4.98
121.28
3.2
1.4
10.24
2.67
ug/l
0.73
238
520
339
895
4.49
118.27
8.7
9.2
95.54
93.33
%
15.11
339
890
338
897
4.46
117.06
8.5
9.1
0.46
0.68
%
20.47
338
889
339
905
4.43
116.46
8.5
9.0
0.92
1.38
%
14.55
339
899
670
2830
3.26
115.57
3.3
2.4
3.97
4.68
e6/l
1.12
616
2523
553
2119
3.39
111.50
4.2
2.8
1.92
2.11
e6/l
0.22
348
1150
533
2006
3.42
110.51
4.6
2.6
0.81
0.82
mmol/l
1.59
513
1850
397
1248
3.85
108.30
7.7
6.9
1.17
1.43
mmol/l
7.92
391
1220
851
4245
3.02
107.90
7.2
2.1
2.36
2.35
mmol/l
1.13
792
3550
482
1799
3.35
100.08
7.6
5.4
1.07
1.02
mmol/l
2.21
458
1663
828
4270
2.84
95.49
4.6
2.4
69.57
60.95
u/l
0.97
788
3915
556
2319
3.08
94.93
4.0
2.6
0.82
1.29
e6/l
1.55
349
1348
685
3213
2.90
94.34
5.4
3.6
91.20
85.11
%
7.68
676
3136
501
2224
2.78
73.53
2.2
1.9
30.04
29.95
s
0.11
495
2153
522
2425
2.67
69.47
6.6
2.1
2.48
2.44
mmol/l
7.51
493
2075
1002
6286
2.46
69.43
7.2
5.8
25.44
27.08
%
4.35
950
5853
749
4141
2.45
68.68
5.0
2.7
32.23
40.04
u/l
1.02
717
3920
311
1098
3.25
68.47
5.7
1.8
387.38
364.59
nmol/l
1.21
302
986
988
6226
2.41
66.77
7.0
5.6
59.61
57.69
%
4.95
936
5794
130
262
5.29
61.65
2.9
1.9
1290.79
31.19
u/ml
0.52
116
208
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
171
436
4.25
60.82
3.0
2.8
0.38
0.34
u/ml
0.58
75
259
416
1842
2.67
59.84
3.2
2.6
20.17
23.50
%
4.66
355
1565
459
2139
2.57
59.41
3.2
2.5
10.98
13.29
umol/l
8.63
436
1989
433
1975
2.60
58.49
3.2
2.5
2.12
2.29
g/l
6.89
412
1833
96
157
6.42
56.64
1.3
1.2
—
—
—
0
0
317
1324
2.72
50.44
3.0
2.3
7.23
8.40
umol/l
0.53
289
1149
135
350
4.10
46.73
5.5
7.5
105.90
105.22
mmol/l
1.04
125
316
262
1032
2.82
46.42
1.8
2.0
0.21
0.20
g/l
0.88
249
934
446
2285
2.29
45.11
1.9
1.8
—
—
—
0
0
1610
13788
4.46
44.70
27.1
13.2
35.59
24.55
mg/l
26.26
1535
10757
317
1420
2.52
43.20
4.1
3.1
—
—
—
0
0
256
1060
2.67
40.89
6.5
2.9
1.23
1.23
mmol/l
0.24
238
891
1320
10430
2.21
39.53
4.7
4.1
18.63
11.96
mm/h
22.61
1230
9614
961
6790
1.96
39.25
4.8
3.6
0.00
0.00
estimate
0.99
257
1242
183
664
2.97
37.38
5.2
5.1
1.79
1.64
%
1.33
172
628
960
6854
1.93
37.18
4.8
3.6
0.01
0.01
estimate
0.12
245
1085
180
654
2.96
36.66
5.2
5.2
0.97
0.88
%
2.58
169
618
332
1656
2.25
34.83
2.4
2.0
1.79
1.77
%
0.16
306
1446
260
1170
2.44
34.57
3.0
1.6
65.83
66.87
g/l
1.28
240
1060
250
1108
2.47
34.35
3.1
2.2
36.72
39.50
u/l
0.22
221
930
939
6773
1.87
33.98
6.7
4.8
0.00
0.00
estimate
-0.00
255
1145
89
221
4.20
32.54
1.4
1.3
14.85
7.17
u/l
3.49
71
182
103
285
3.78
32.44
4.3
4.7
2.48
2.77
mmol/l
0.41
72
184
227
989
2.50
32.26
6.2
7.1
24.16
24.52
mmol/l
0.78
216
947
79
180
4.55
32.25
1.4
1.2
0.19
0.43
nmol/l
—
7
15
290
1427
2.25
31.18
5.5
3.5
1.49
2.11
mmol/l
1.74
246
1209
242
1102
2.40
31.17
5.5
3.8
126.85
95.31
ng/l
3.35
215
947
69
145
4.92
31.05
1.5
1.2
29.12
28.71
iu/l
0.03
50
123
553
3449
1.90
30.95
2.3
2.2
3.17
2.91
mg/l
1.40
478
2900
212
912
2.51
30.90
1.7
1.6
—
—
—
0
0
289
1439
2.22
30.11
5.5
3.4
5.98
5.86
kpa
1.34
283
1392
308
1617
2.11
27.87
1.8
1.7
—
—
—
0
0
744
5216
1.76
27.52
3.3
2.8
215.66
147.06
ug/l
5.24
673
4756
305
1608
2.09
27.25
1.8
1.8
—
—
—
0
0
253
1250
2.20
26.67
2.8
2.1
69.71
68.21
e9/l
0.25
188
954
1632
14838
3.82
26.11
35.6
16.1
138.98
139.82
mmol/l
35.43
1627
14445
803
5811
1.73
26.09
4.5
3.8
103.00
60.43
ng/l
0.30
648
4303
1633
14881
3.79
25.43
36.0
16.2
4.08
4.00
mmol/l
24.80
1627
14462
197
898
2.35
25.09
4.4
3.2
1.58
1.86
mmol/l
0.42
141
642
1386
11797
1.97
25.03
36.4
15.4
15.55
15.22
%
1.23
1380
11543
159
662
2.55
24.67
1.6
1.5
1.81
1.51
g/l
2.44
135
570
140
551
2.68
24.34
1.9
1.8
0.92
1.69
ug/l
1.30
127
487
203
954
2.28
24.05
4.4
3.3
5.14
5.17
kpa
0.21
191
900
73
197
3.83
23.82
3.0
5.7
1362.25
504.04
iu/ml
—
8
26
101
338
3.11
23.61
2.6
2.7
1.88
1.63
mg/l
2.01
92
300
60
144
4.28
22.95
1.4
1.5
1276.65
1635.74
e6/l
0.49
40
102
91
300
3.15
21.82
3.0
2.3
16.35
16.90
%
0.53
58
164
82
254
3.34
21.77
1.3
1.5
—
—
—
0
0
569
3953
1.66
20.09
3.2
2.5
2143.46
6609.08
umol/l
2.37
497
3413
1228
10331
1.69
19.80
7.2
3.6
15.15
14.98
pmol/l
1.49
1121
9276
180
872
2.19
19.69
2.0
1.6
—
—
—
0
0
708
5231
1.61
19.31
3.4
3.2
7.32
7.68
mmol/l
1.34
578
4408
45
99
4.64
19.21
1.2
1.3
338.59
298.56
u/l
0.22
45
94
695
5120
1.61
19.14
3.4
3.3
653.53
166.85
mg/l
1.67
453
3314
707
5233
1.60
19.07
5.4
3.8
—
—
—
0
0
52
130
4.10
18.87
1.3
1.5
34208.56
81475.96
e6/l
0.47
25
77
77
252
3.15
18.71
1.4
1.9
2.14
4.61
iu/l
3.18
18
82
57
155
3.77
18.43
2.4
1.9
19.12
27.09
u/ml
0.45
51
140
720
5386
1.59
18.36
4.1
3.9
22.95
7.73
mg/mmol
5.56
459
3458
29
46
6.40
17.58
2.1
2.3
—
—
—
0
0
135
611
2.31
17.36
4.8
3.0
4.28
4.47
pmol/l
1.01
124
524
1051
8638
1.57
17.33
3.6
3.0
68.47
51.26
u/l
4.91
968
7900
95
372
2.65
16.66
1.9
1.7
—
—
—
0
0
449
3067
1.63
16.33
4.9
3.9
2366.17
506.44
ng/l
0.47
387
2576
1478
13329
1.86
16.01
32.2
12.2
62.81
76.56
ml/min/173m2
96.50
1364
10783
1433
12807
1.78
15.97
7.8
4.4
2.18
2.09
mu/l
0.39
1325
11557
51
142
3.67
15.96
1.0
1.1
—
—
—
0
0
426
2889
1.63
15.88
1.7
1.6
1.79
1.27
mg/l
1.72
358
2228
34
72
4.80
15.21
1.2
1.3
10.28
10.05
u/l
0.05
29
64
635
4785
1.52
14.75
3.1
3.0
1880.62
1493.01
ng/l
1.09
574
4111
1609
15038
2.43
14.53
18.3
9.3
27.59
26.85
u/l
0.38
1575
14379
210
1201
1.85
14.29
4.0
2.8
4.52
4.52
kpa
0.01
202
1157
511
3711
1.54
13.91
5.1
3.9
0.00
0.00
estimate
0.13
228
1099
502
3639
1.54
13.75
1.6
1.5
18.55
20.34
nmol/l
1.85
436
3035
100
445
2.33
13.38
2.2
3.0
—
—
—
0
0
25
45
5.62
13.38
2.3
1.4
—
—
—
0
0
1636
15467
2.74
13.32
44.4
19.5
38.92
40.61
%
20.90
1510
14254
1636
15482
2.71
13.01
43.7
19.4
7.23
6.75
e9/l
13.20
1616
14952
1636
15483
2.71
12.99
43.8
19.4
245.28
240.85
e9/l
1.80
1621
15015
1636
15487
2.70
12.90
43.6
19.4
4.37
4.54
e12/l
27.42
1614
14951
89
383
2.40
12.85
1.2
1.2
—
—
—
0
0
98
442
2.29
12.72
2.2
1.5
54.31
48.19
mg/l
0.36
74
359
95
424
2.31
12.63
2.3
1.5
1.79
4.02
ratio
—
6
36
21
16
13.27
12.43
2.2
2.9
—
—
—
0
0
97
440
2.28
12.42
2.2
1.5
109.77
33.56
mg/l
0.74
72
357
60
220
2.79
12.00
3.9
3.3
59.37
58.27
%
0.26
60
220
80
339
2.43
11.96
2.8
1.9
130.48
134.38
g/l
0.63
69
252
151
823
1.92
11.88
1.6
1.5
—
—
—
0
0
59
217
2.78
11.74
3.7
3.2
4.51
4.41
e9/l
0.13
59
217
71
291
2.50
11.41
1.3
1.4
—
—
—
0
0
612
4786
1.44
10.94
2.1
2.2
246.43
231.55
u/l
0.12
573
4471
855
7104
1.41
10.83
2.6
2.3
—
—
—
0
0
48
168
2.91
10.48
1.3
1.4
236.41
341.99
pmol/l
1.64
41
143
773
6347
1.40
10.30
2.1
2.0
92.16
93.61
pmol/l
0.34
449
3261
103
526
2.02
9.79
2.0
1.6
—
—
—
0
0
62
257
2.47
9.76
1.2
1.5
—
—
—
0
0
678
5483
1.39
9.70
2.5
2.2
79.04
78.07
nmol/l
0.34
617
4791
31
87
3.61
9.67
1.2
1.4
—
—
—
0
0
25
60
4.21
9.65
1.3
1.3
—
—
—
0
0
49
184
2.71
9.43
1.1
1.4
—
—
—
0
0
149
870
1.78
9.42
2.6
2.2
10.42
10.87
g/l
0.50
137
794
107
569
1.94
9.08
2.0
1.7
—
—
—
0
0
61
263
2.37
8.85
1.2
1.4
—
—
—
0
0
36
119
3.07
8.72
1.1
1.5
—
—
—
0
0
23
57
4.08
8.53
1.3
1.4
—
—
—
0
0
23
57
4.08
8.53
1.3
1.4
—
—
—
0
0
76
372
2.09
8.14
1.3
1.4
237.61
296.65
ug/g
1.80
51
224
116
660
1.81
8.01
1.3
1.2
177.32
123.99
iu/ml
0.46
34
258
25
70
3.61
7.86
1.2
1.3
—
—
—
0
0
65
307
2.16
7.64
1.8
2.7
27.82
37.56
umol/l
2.01
55
278
49
205
2.43
7.63
1.3
1.4
—
—
—
0
0
103
575
1.84
7.57
1.6
1.4
3.83
3.75
g/l
0.22
92
513
103
576
1.84
7.53
1.6
1.4
—
—
—
0
0
103
576
1.84
7.53
1.6
1.4
8.06
7.49
g/l
1.82
92
512
14
14
10.07
7.53
1.1
1.1
—
—
—
0
0
29
93
3.16
7.42
1.2
1.1
—
—
—
0
0
41
161
2.58
7.29
1.2
1.4
—
—
—
0
0
44
182
2.46
7.04
1.3
1.3
—
—
—
0
0
40
158
2.57
7.04
1.3
1.3
—
—
—
0
0
26
81
3.24
6.98
1.7
1.8
—
—
—
0
0
17
27
6.35
6.94
1.5
1.3
26.71
31.00
%
0.19
17
19
96
541
1.82
6.87
1.5
1.4
10.69
10.29
g/l
0.31
84
475
94
539
1.79
6.37
1.6
1.4
3.22
2.96
g/l
1.30
83
477
33
125
2.67
6.33
2.2
2.4
—
—
—
0
0
37
154
2.43
5.89
1.9
2.3
685.67
633.73
ml
0.35
27
98
84
483
1.78
5.67
1.8
1.4
1.02
0.35
g/l
0.67
69
421
43
196
2.23
5.59
1.9
1.4
111.13
112.43
u/ml
0.04
15
34
20
62
3.25
5.45
1.1
1.3
214.95
175.28
mmol/24h
0.59
20
62
37
162
2.31
5.30
1.2
1.4
—
—
—
0
0
372
2964
1.33
5.24
1.8
1.8
1090.71
1168.48
nmol/l
0.94
303
2226
14
26
5.42
5.22
1.2
1.2
—
—
—
0
0
141
2040
0.66
5.17
9.6
6.6
—
—
—
0
0
13
24
5.45
4.91
1.2
1.1
317.72
1.23
ug/l
—
6
6
79
468
1.72
4.85
2.2
2.2
164.88
93.18
ug/min
0.58
45
290
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
19
62
3.09
4.79
1.2
1.1
—
—
—
0
0
51
270
1.92
4.53
1.4
1.7
—
—
—
0
0
23
87
2.67
4.49
1.4
1.5
—
—
—
0
0
153
1079
1.46
4.48
2.0
2.2
11.79
14.83
nmol/l
4.91
137
947
788
6994
1.24
4.46
5.1
3.8
2.57
1.95
ug/l
4.20
697
6310
19
65
2.94
4.45
1.1
1.1
—
—
—
0
0
111
734
1.55
4.43
3.2
2.5
0.62
0.65
%
0.45
111
729
113
752
1.54
4.39
3.2
2.5
1.18
1.27
%
0.52
113
745
40
197
2.06
4.35
1.2
1.2
—
—
—
0
0
15
38
3.97
4.30
1.4
1.7
91.47
72.24
nmol/24h
0.19
15
38
30
133
2.28
4.23
1.2
1.4
277.76
275.66
mosm/kgh2o
0.12
21
98
72
436
1.68
4.13
1.5
1.4
0.00
0.01
g/l
0.59
66
402
10
17
5.91
4.13
1.0
1.2
—
—
—
0
0
68
408
1.69
4.04
1.5
1.4
0.00
0.00
g/l
-0.00
63
375
75
465
1.64
3.95
1.5
1.3
36.53
37.79
g/l
0.95
64
403
10
19
5.29
3.83
1.0
1.2
2.27
1.93
umol/l
—
10
19
192
1453
1.36
3.78
2.9
3.0
275.11
201.32
ng/l
0.83
180
1342
277
2224
1.29
3.62
1.6
1.3
2.86
2.72
g/l
0.34
170
1288
159
1177
1.39
3.60
4.2
2.3
47.84
63.18
ml/min/173m2
8.98
94
450
28
131
2.16
3.52
1.4
1.3
—
—
—
0
0
51
302
1.71
3.24
1.7
1.3
—
—
—
0
0
26
123
2.13
3.20
1.2
1.4
—
—
—
0
0
42
237
1.79
3.15
1.3
1.1
—
—
—
0
0
36
200
1.82
2.86
1.3
1.2
240.23
270.91
u/ml
0.32
22
120
38
215
1.79
2.85
1.2
1.2
—
—
—
0
0
46
276
1.69
2.82
1.2
1.3
—
—
—
0
0
32
172
1.88
2.82
4.2
44.4
6.91
7.55
mmol/l
0.70
25
141
47
286
1.66
2.74
1.3
1.3
—
—
—
0
0
47
286
1.66
2.74
1.3
1.3
—
—
—
0
0
23
111
2.09
2.73
1.2
1.4
—
—
—
0
0
16
66
2.44
2.71
2.2
1.7
221.56
203.68
u/l
0.44
16
66
16
67
2.40
2.63
1.3
1.4
—
—
—
0
0
463
4062
1.19
2.63
1.7
1.7
1.59
1.37
mmol/l
5.38
383
3361
12
41
2.94
2.62
1.0
1.3
—
—
—
0
0
12
41
2.94
2.62
1.0
1.3
—
—
—
0
0
32
179
1.80
2.52
1.2
1.4
—
—
—
0
0
32
179
1.80
2.52
1.2
1.4
—
—
—
0
0
307
2606
1.22
2.46
1.2
1.2
2.35
1.77
u/ml
0.16
67
687
1463
14172
1.24
2.37
5.8
5.0
6.23
6.09
mmol/l
3.04
1314
12815
13
52
2.51
2.36
1.1
1.1
—
—
—
0
0
171
1375
1.27
2.25
2.7
2.2
339.78
168.80
ug/g
0.68
133
1097
15
67
2.25
2.18
1.3
1.3
—
—
—
0
0
9
30
3.01
2.15
1.0
1.3
—
—
—
0
0
9
30
3.01
2.15
1.0
1.3
—
—
—
0
0
9
30
3.01
2.15
1.0
1.3
—
—
—
0
0
10
36
2.79
2.14
1.2
1.1
—
—
—
0
0
1415
13697
1.20
2.10
6.9
6.4
41.36
40.77
mmol/mol
1.43
1313
12628
10
37
2.71
2.07
1.2
1.1
—
—
—
0
0
13
56
2.33
2.05
1.2
1.3
—
—
—
0
0
13
56
2.33
2.05
1.2
1.3
—
—
—
0
0
27
154
1.77
2.04
1.3
1.2
—
—
—
0
0
23
125
1.85
2.03
1.9
1.2
—
—
—
0
0
10
38
2.64
2.00
3.5
1.9
—
—
—
0
0
15
70
2.15
1.98
2.6
2.3
—
—
—
0
0
5
11
4.56
1.94
1.0
1.1
—
—
—
0
0
18
92
1.97
1.90
1.2
1.2
—
—
—
0
0
18
92
1.97
1.90
1.2
1.2
—
—
—
0
0
18
92
1.97
1.90
1.2
1.2
—
—
—
0
0
69
938
0.72
1.89
2.0
1.9
—
—
—
0
0
26
151
1.73
1.87
1.2
1.2
—
—
—
0
0
11
46
2.40
1.85
1.2
1.3
—
—
—
0
0
11
46
2.40
1.85
1.2
1.3
—
—
—
0
0
26
153
1.71
1.80
1.3
1.2
—
—
—
0
0
8
29
2.77
1.79
2.0
1.6
236.25
181.35
ng/l
—
8
29
8
29
2.77
1.79
2.1
2.4
1.23
1.20
mmol/l
—
8
29
70
515
1.37
1.77
1.4
1.6
112.00
282.58
titre
—
5
31
355
3146
1.16
1.74
5.4
4.0
1.02
1.02
kg/l
0.01
70
465
49
339
1.46
1.74
1.4
1.9
11.11
11.94
mg/l
0.31
44
310
9
36
2.51
1.74
1.1
2.3
—
6627.80
—
0
5
12
244
0.49
1.74
1.2
1.4
—
—
—
0
0
178
1486
1.22
1.72
1.4
1.3
—
—
—
0
0
22
125
1.77
1.72
1.1
1.1
—
—
—
0
0
30
187
1.62
1.69
2.0
2.4
16.47
20.88
mg/l
—
10
41
51
358
1.44
1.69
1.1
1.1
—
—
—
0
0
6
19
3.17
1.66
1.2
1.2
—
—
—
0
0
5
14
3.58
1.61
1.0
1.2
—
—
—
0
0
50
355
1.42
1.57
1.1
1.1
—
—
—
0
0
15
78
1.93
1.54
1.1
1.0
—
—
—
0
0
5
15
3.34
1.52
1.0
1.1
—
—
—
0
0
5
15
3.34
1.52
1.2
1.0
—
—
—
0
0
6
21
2.86
1.50
4.3
4.0
—
—
—
0
0
5
125
0.40
1.50
1.6
1.5
104.58
227.21
pmol/l
—
5
125
13
65
2.01
1.48
1.4
1.3
—
—
—
0
0
73
558
1.32
1.48
1.4
1.8
39.06
38.93
u/l
0.02
61
471
16
87
1.85
1.46
1.3
1.3
1.73
1.12
nmol/l
—
10
63
7
28
2.51
1.45
1.6
1.8
—
—
—
0
0
24
148
1.63
1.44
1.3
1.3
—
—
—
0
0
24
148
1.63
1.44
1.3
1.3
—
—
—
0
0
61
456
1.35
1.44
1.6
1.4
—
—
—
0
0
14
73
1.93
1.44
2.2
1.5
2.86
4.63
u/field
0.27
14
53
5
16
3.13
1.44
2.0
2.2
0.00
0.63
u/field
—
5
16
432
3933
1.13
1.43
3.2
2.7
0.89
0.71
ug/l
3.58
325
2630
9
39
2.31
1.43
1.1
1.1
—
—
—
0
0
9
39
2.31
1.43
1.1
1.1
—
—
—
0
0
9
40
2.26
1.40
2.3
2.8
—
—
—
0
0
9
40
2.26
1.40
2.3
2.8
—
—
—
0
0
48
347
1.39
1.39
5.5
2.9
7.05
7.62
mmol/l
1.15
48
332
43
305
1.42
1.39
1.1
1.3
—
431.43
—
0
7
24
150
1.61
1.38
1.3
1.2
—
—
—
0
0
9
43
2.10
1.30
2.2
1.3
13.97
8.88
ug/l
—
9
43
8
34
2.36
1.29
1.1
1.1
—
—
—
0
0
5
18
2.78
1.28
1.2
1.2
—
—
—
0
0
6
25
2.40
1.24
1.2
1.2
—
—
—
0
0
8
36
2.23
1.24
1.4
1.2
123.75
113.58
%
—
8
31
365
3321
1.13
1.22
1.7
1.7
42905798.44
40862617.03
pmol/l
0.02
296
2714
62
479
1.31
1.21
5.0
4.2
4.00
3.94
mmol/l
0.32
62
474
20
124
1.62
1.21
1.1
1.1
—
—
—
0
0
12
64
1.88
1.18
1.1
1.1
—
—
—
0
0
14
79
1.78
1.17
1.2
1.2
—
—
—
0
0
14
79
1.78
1.17
1.2
1.2
—
—
—
0
0
14
81
1.73
1.09
1.3
1.2
—
—
—
0
0
7
32
2.19
1.08
1.0
1.1
—
—
—
0
0
29
202
1.44
1.08
1.9
1.5
81.65
62.84
%
2.78
17
124
46
349
1.33
1.05
1.7
1.6
—
—
—
0
0
5
22
2.28
1.03
1.0
1.5
—
—
—
0
0
599
5643
1.10
1.03
4.2
3.7
23.03
24.17
%
1.08
316
2686
48
369
1.31
1.01
5.5
2.8
1.43
1.68
mmol/l
1.50
48
353
46
352
1.32
1.00
1.1
1.2
3.73
3.61
u/ml
—
7
52
7
35
2.00
1.00
1.1
1.1
—
—
—
0
0
19
123
1.55
0.99
1.7
2.0
5.20
1.82
u/field
—
10
45
46
355
1.30
0.95
2.1
1.7
—
—
—
0
0
22
151
1.46
0.90
3.3
4.0
—
—
—
0
0
50
394
1.28
0.90
1.6
1.6
0.62
7.49
iu/ml
—
6
84
15
96
1.57
0.84
1.3
1.2
2.71
2.01
mmol/l
0.76
15
91
8
46
1.74
0.82
1.4
1.1
—
—
—
0
0
20
139
1.44
0.79
1.3
1.5
—
—
—
0
0
20
139
1.44
0.79
1.3
1.5
—
—
—
0
0
11
66
1.67
0.78
2.5
2.5
38045.45
40807.58
ug/l
0.25
11
66
11
67
1.65
0.75
1.4
1.1
1.00
1.15
u/l
—
6
30
12
76
1.58
0.71
1.1
1.2
504.83
414.77
u/l
0.08
12
69
13
194
0.67
0.71
1.5
1.5
—
—
—
0
0
5
27
1.85
0.68
1.4
1.1
—
—
—
0
0
15
102
1.47
0.67
1.7
1.7
91.07
90.45
umol/l
0.02
15
102
41
330
1.25
0.66
2.0
1.5
0.92
0.85
nmol/l
0.26
35
273
30
233
1.29
0.64
1.0
1.1
1.67
95.06
iu/ml
—
9
43
25
326
0.76
0.64
5.0
3.4
34.80
29.55
mg/l
0.26
20
211
40
323
1.24
0.64
2.6
3.2
0.82
0.80
nmol/l
0.13
33
253
239
2221
1.09
0.58
1.3
1.3
35.99
38.46
iu/ml
0.08
79
678
8
54
1.48
0.57
1.4
1.3
—
—
—
0
0
126
1135
1.12
0.57
1.3
1.4
—
—
—
0
0
167
1532
1.10
0.54
2.2
2.4
5.99
7.87
ug/l
0.61
150
1355
9
61
1.48
0.53
1.1
1.1
—
—
—
0
0
6
39
1.54
0.53
1.5
1.1
—
—
—
0
0
6
97
0.62
0.52
1.0
1.2
—
—
—
0
0
6
97
0.62
0.52
1.0
1.2
—
—
—
0
0
6
97
0.62
0.52
1.8
1.4
1.05
0.94
g/l
—
6
97
6
97
0.62
0.52
1.0
1.2
—
—
—
0
0
37
445
0.83
0.51
1.5
1.8
40.38
41.61
nmol/l
0.12
37
423
212
1974
1.08
0.51
4.4
4.9
30.61
32.80
%
2.24
153
1310
24
189
1.27
0.49
1.1
1.2
9.27
3.11
u/ml
0.43
11
64
59
511
1.16
0.49
1.2
1.2
—
—
—
0
0
17
128
1.33
0.47
1.1
1.1
—
78.33
—
0
6
19
146
1.30
0.47
1.4
1.4
13.15
25.19
%
—
8
91
8
56
1.43
0.42
1.1
1.0
—
—
—
0
0
6
94
0.64
0.42
1.0
1.2
—
—
—
0
0
6
94
0.64
0.42
1.0
1.2
—
—
—
0
0
158
1470
1.08
0.41
1.6
1.8
1.50
1.57
%
0.56
131
1268
20
159
1.26
0.40
1.3
1.4
—
—
—
0
0
5
35
1.43
0.39
1.8
1.5
0.41
0.40
ug/l
—
5
19
36
308
1.17
0.37
1.2
1.1
—
—
—
0
0
5
37
1.35
0.37
1.0
1.1
—
—
—
0
0
5
78
0.64
0.35
1.6
1.3
1.55
1.54
g/l
—
5
78
6
45
1.33
0.33
1.0
1.2
—
—
—
0
0
6
45
1.33
0.33
1.2
1.1
680.50
1621.11
miu/ml
—
6
45
1429
14169
1.05
0.33
4.8
4.8
1.30
1.41
mmol/l
24.28
1284
12957
22
182
1.21
0.33
1.1
1.2
9.00
6.90
u/ml
0.19
12
89
11
83
1.33
0.32
1.5
1.1
60.34
35.75
mg/l
0.89
11
73
1383
13712
1.05
0.30
4.3
4.3
1.51
1.31
mmol/l
13.42
1235
12426
23
194
1.19
0.29
1.7
1.4
—
—
—
0
0
7
57
1.23
0.29
2.7
4.5
—
—
—
0
0
1439
14287
1.05
0.27
4.8
4.9
4.39
4.51
mmol/l
4.62
1308
13166
8
65
1.23
0.27
1.1
1.2
—
—
—
0
0
9
76
1.19
0.24
1.3
1.0
—
—
—
0
0
1471
14621
1.05
0.24
5.3
5.5
2.56
2.65
mmol/l
3.24
1318
13412
16
133
1.20
0.24
2.1
2.3
—
—
—
0
0
19
161
1.18
0.24
1.2
1.2
—
—
—
0
0
6
85
0.70
0.24
1.2
1.7
17.75
16.16
nmol/l
—
6
72
13
158
0.82
0.23
1.9
1.3
78834.29
141086.15
e6/l
—
7
111
5
40
1.25
0.22
2.0
2.5
568.20
414.14
e6/l
—
5
29
5
40
1.25
0.22
1.0
1.4
—
—
—
0
0
5
41
1.22
0.22
1.0
1.1
81.20
100.66
%
—
5
32
0
10
0.00
0.21
0.0
1.4
—
10.90
—
0
10
35
315
1.11
0.21
1.5
1.3
94.88
33.72
e6/l
0.30
25
257
35
315
1.11
0.21
1.5
1.4
883.16
1035.24
e6/l
0.07
25
267
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
8
105
0.76
0.21
1.8
3.2
13.70
13.28
%
—
8
105
14
166
0.84
0.20
1.4
1.8
—
—
—
0
0
41
447
0.92
0.19
2.0
1.7
—
—
—
0
0
10
81
1.24
0.18
1.3
1.0
378.30
255.81
mg/l
—
10
73
52
560
0.93
0.18
1.0
1.0
—
—
—
0
0
12
142
0.84
0.17
1.1
1.1
1.00
1.73
u/ml
—
5
66
6
80
0.75
0.15
1.2
1.0
—
—
—
0
0
17
192
0.88
0.14
1.1
1.0
—
—
—
0
0
54
572
0.94
0.13
1.4
1.6
—
—
—
0
0
12
138
0.87
0.13
1.4
1.7
—
—
—
0
0
20
182
1.10
0.11
1.0
1.1
—
—
—
0
0
33
309
1.07
0.10
1.3
1.3
—
—
—
0
0
6
58
1.03
0.08
1.2
1.1
316.67
254.14
iu/ml
—
6
58
211
2130
0.99
0.04
1.2
1.2
18.90
15.25
u/ml
0.16
59
807
52
508
1.02
0.03
1.3
1.6
—
—
—
0
0
42
410
1.03
0.02
1.9
1.6
13470.86
13093.14
e6/l
0.03
29
304
11
103
1.07
0.02
1.0
1.0
—
—
—
0
0
10
101
0.99
0.00
1.5
1.4
—
55.71
—
0
7
10
98
1.02
0.00
1.1
1.2
12.04
9.74
mmol/l
—
10
88
0
8
0.00
0.00
0.0
1.7
—
—
—
0
0
6
65
0.92
0.00
1.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.5
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.1
—
2.33
—
0
7
5
59
0.85
-0.00
1.4
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
54
0.93
-0.00
1.0
1.2
—
18.00
u/ml
—
0
7
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_KIDNEY_CLEAR_CELL_CARCINOMA – Clear cell adenocarcinoma of kidney
GWS hits: 5
This endpoint is excluded from FinRegistry analyses (omitted endpoint).